Wald test MLE group comparisons for rs2230531
| Frequency comparison . | χ2 (1 df) . | P . |
|---|---|---|
| TFHMS vs TPC/TCC | 0.163 | .686 |
| TFHMS vs non-TCGA NFE ExAC | 1.408 | .235 |
| TPC/TCC vs non-TCGA NFE ExAC | 2.162 | .141 |
| Tasmania vs non-TCGA NFE ExAC | 3.3 | .069 |
| Frequency comparison . | χ2 (1 df) . | P . |
|---|---|---|
| TFHMS vs TPC/TCC | 0.163 | .686 |
| TFHMS vs non-TCGA NFE ExAC | 1.408 | .235 |
| TPC/TCC vs non-TCGA NFE ExAC | 2.162 | .141 |
| Tasmania vs non-TCGA NFE ExAC | 3.3 | .069 |
For the non-TCGA NFE population of the ExAC, the MAF for rs2230531 is 0.0073853. For the TFHMS, the MAF is 0.013436. For the TPC and TCC samples, the combined MAF is 0.0111437. Across all Tasmanian samples (TFHMS/TPC/TCC), the MAF is 0.01157.
df, degrees of freedom; non-TCGA NFE ExAC, non–The Cancer Genome Atlas, non–Finnish European component of the ExAC.